Location History:
- Wantage, GB (2005 - 2010)
- Oxon, GB (2006 - 2010)
- Oxford, GB (2006 - 2011)
Company Filing History:
Years Active: 2005-2011
Title: Kevin Alan Myers: Innovator in Tumor-Targeting Vectors
Introduction
Kevin Alan Myers is a distinguished inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of vectors that target tumors. With a total of 14 patents to his name, Myers has established himself as a key figure in innovative medical solutions.
Latest Patents
Among his latest patents, Myers has developed a vector comprising a nucleotide sequence of interest (NOI) that encodes a product of interest (POI). This vector is designed to recognize tumors, allowing for the targeted delivery of the NOI and/or the POI directly to the tumor site. This innovative approach has the potential to enhance the effectiveness of cancer treatments.
Career Highlights
Throughout his career, Myers has worked with notable companies, including Oxford Biomedica Limited and Oxford Biomedica, Inc. His work in these organizations has contributed to advancements in gene therapy and cancer treatment methodologies.
Collaborations
Myers has collaborated with esteemed colleagues such as Miles William Carroll and Christopher Robert Bebbington. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kevin Alan Myers is a prominent inventor whose work in tumor-targeting vectors has the potential to revolutionize cancer treatment. His contributions to biotechnology and his collaborations with other experts highlight his commitment to advancing medical science.